AgeTech World: Longevity Will Never Be a Magic Pill That Will Make Us Younger

As the founder of LongeVC, my journey through the longevity landscape is personal and professional. I have witnessed first-hand the devastating effects of age-related diseases, driving me to seek and support groundbreaking advancements in consumer health, biotech, and AI for drug discovery. Our mission is clear: to foster a future where age does not dictate our health.

I've encountered common misconceptions about longevity in this rapidly growing sector, which is expected to expand significantly by 2030. It’s crucial to differentiate evidence-based medical practises from costly and unregulated treatments in some clinics. At LongeVC, we invest in the former—therapies and technologies grounded in solid research, promising a real extension of healthy human life.

Our investment philosophy extends beyond the medical. We advocate for systemic change, from insurance to pension plans, preparing society for the realities of an extended lifespan. Our portfolio reflects this vision, with companies like Haut.AI revolutionising personalised skin care through AI and Freedom Biosciences making strides in affordable mental health treatment.

For the whole narrative of how we're shaping the longevity industry and details on our strategic investments, click here and read the article.